 Connection
Pamela Peterson to Drug Monitoring
This is a "connection" page, showing publications Pamela Peterson has written about Drug Monitoring.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.318 |
|
|
|
-
Fletcher DR, Sandy LM, Waughtal J, Hoffman C, Novins-Montague S, Hosokawa P, Peterson PN, Allen LA, Bull S, Ho PM. Cost of behavioral messaging interventions for cardiovascular medication adherence. Am J Manag Care. 2026 Jun 01; 32(6):e205-e211.
Score: 0.186
-
Luo N, Lippmann SJ, Mentz RJ, Greiner MA, Hammill BG, Hardy NC, Laskey WK, Heidenreich PA, Chang CL, Hernandez AF, Curtis LH, Peterson PN, Fonarow GC, O'Brien EC. Relationship Between Hospital Characteristics and Early Adoption of Angiotensin-Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure. J Am Heart Assoc. 2019 02 05; 8(3):e010484.
Score: 0.112
-
Clarke CL, Grunwald GK, Allen LA, Barón AE, Peterson PN, Brand DW, Magid DJ, Masoudi FA. Natural history of left ventricular ejection fraction in patients with heart failure. Circ Cardiovasc Qual Outcomes. 2013 Nov; 6(6):680-6.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|